Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,616.85
(
0.08%
)
US TECH 100
23,571.20
(
0.13%
)
Dow Jones
46,584.46
(
-0.18%
)
Brent Oil
101.08
(
-5.59%
)
Bitcoin
69,901.57
(
1.52%
)
News Focus
News Focus
Post# of 820676
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

LearningEveryTrade

Send PM Follow Ignore
Followers 21
Posts 1402
Boards Moderated 0
Alias Born 03/03/2021

LearningEveryTrade

Re: Maverick0408 post# 518367

Sunday, 10/02/2022 11:06:27 PM

Sunday, October 02, 2022 11:06:27 PM

Post# of 820676
The reality is, why stretch out a trial? To get 5,7, and perhaps 10 year OS data. I am certain they did not plan this originally, but when they realized how good DCVAX can be, it makes sense. Good luck to competition running a trial long enough to get the long OS data.

Most biotechs fail, they follow the same strategy. A path never traveled is always GROUNDBREAKING... and your get GROUNDBREAKING results.

ASM= Actively Supporting Management

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News